Search hospitals
>
New Jersey
>
Hackensack
John Theurer Cancer Center at Hackensack University Medical Center
Claim this profile
Hackensack, New Jersey 07601
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Solid Tumors
Conducts research for Leukemia
Conducts research for Multiple Myeloma
346 reported clinical trials
18 medical researchers
Summary
John Theurer Cancer Center at Hackensack University Medical Center is a medical facility located in Hackensack, New Jersey. This center is recognized for care of Cancer, Lung Cancer, Solid Tumors, Leukemia, Multiple Myeloma and other specialties. John Theurer Cancer Center at Hackensack University Medical Center is involved with conducting 346 clinical trials across 253 conditions. There are 18 research doctors associated with this hospital, such as Martin E Gutierrez, Robert Alter, MD, Donna McNamara, MD, and Tatyana Feldman, MD.
Area of expertise
Cancer
John Theurer Cancer Center at Hackensack University Medical Center has run 60 trials for Cancer. Some of their research focus areas include:
Lung Cancer
John Theurer Cancer Center at Hackensack University Medical Center has run 51 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Martin E Gutierrez
John Theurer Cancer Center at Hackensack University Medical Center
3 years of reported clinical research
Robert Alter, MD
Hackensack University Medical Center
8 years of reported clinical research
Donna McNamara, MD
Hackensack University Medical Center
3 years of reported clinical research
Tatyana Feldman, MD
Hackensack University Medical Center
1 year of reported clinical research
Clinical Trials running at John Theurer Cancer Center at Hackensack University Medical Center
Lung Cancer
Cancer
Solid Tumors
Breast Cancer
Multiple Myeloma
Non-Small Cell Lung Cancer
Prostate Cancer
Colorectal Cancer
Myelodysplastic Syndrome
Ovarian Cancer
Anti-CD38 + KRAS Vaccine + Anti-PD-1
for Pancreatic & Lung Cancer
The goal of this clinical trial is to test the safety and tolerability of anti-CD38 monoclonal antibody (mAb), daratumumab, in combination with KRAS vaccine (Targovax TG-01/Stimulon QS-21) when given with anti-PD-1 (programmed cell death protein 1) mAb (nivolumab) in patients with advanced non-small cell lung cancer (NSCLC) or pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are: * How well does daratumumab and nivolumab, when given with a vaccine, control or stop these types of cancer? * How well does participants bodies handle these study drugs? * Does this combination of study drugs help participants live longer? Participants will receive daratumumab, nivolumab with KRAS vaccine and have regular tests and procedures to follow how the participants are doing on these study drugs.
Recruiting
1 award
Phase 2
13 criteria
V940 + Pembrolizumab
for Lung Cancer
This trial is testing a new treatment combination of V940 and pembrolizumab in patients who have had surgery to remove Stage II, IIIA, or IIIB non-small cell lung cancer. The goal is to see if this new combination can help prevent the cancer from coming back. V940 and pembrolizumab work together to help the immune system find and destroy any leftover cancer cells.
Recruiting
1 award
Phase 3
7 criteria
PF-06821497
for Small Cell Lung Cancer
This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.
Recruiting
1 award
Phase 1
5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at John Theurer Cancer Center at Hackensack University Medical Center?
John Theurer Cancer Center at Hackensack University Medical Center is a medical facility located in Hackensack, New Jersey. This center is recognized for care of Cancer, Lung Cancer, Solid Tumors, Leukemia, Multiple Myeloma and other specialties. John Theurer Cancer Center at Hackensack University Medical Center is involved with conducting 346 clinical trials across 253 conditions. There are 18 research doctors associated with this hospital, such as Martin E Gutierrez, Robert Alter, MD, Donna McNamara, MD, and Tatyana Feldman, MD.
Where is John Theurer Cancer Center at Hackensack University Medical Center located?
The John Theurer Cancer Center at Hackensack University Medical Center is located at 92 2nd St, Hackensack, NJ 07601. For directions, take the I-80 West to Exit 66 toward Hackensack Avenue South, continue onto Hackensack Avenue, then turn left onto Second Street. The hospital will be on your right.
Who should I call to ask about financial aid or insurance network?
**John Theurer Cancer Center at Hackensack University Medical Center Contact Information:** - **Financial Assistance Department:** Call 551-996-4343 - **Insurance Department:** Call 855-513-5897
What insurance does John Theurer Cancer Center at Hackensack University Medical Center accept?
The John Theurer Cancer Center at Hackensack University Medical Center accepts a wide range of insurance plans, including Medicare. For information on specific insurance plans and coverage, please contact the hospital directly at 201.666.3900.
What awards or recognition has John Theurer Cancer Center at Hackensack University Medical Center received?
John Theurer Cancer Center at Hackensack University Medical Center is recognized as the best cancer center in New Jersey by U.S. News & World Report and Newsweek. It is part of the National Cancer Institute-approved Georgetown Lombardi Comprehensive Cancer Center Consortium, focusing on improving cancer outcomes and reducing disparities. The center's investigators are pivotal in introducing significant anticancer drugs to the market through unique collaborations.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.